Back to Search

A Phase 1 Study of Pacritinib in vacuoles, E1 ubiqutin-activating enzyme, X-linked, autoinflammatory, somatic (VEXAS) Syndrome

  • Protocol Number: 202412141
  • Principal Investigator: Jacoby, Meagan
  • Cancer Types: Leukemia, Myeloma, and Hematologic

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]